Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (201-210 of 681) with videos related to

Pageof 69
Sort By:
Scientific Reports|October 20, 2020
Health system utilization before age 1 among children later diagnosed with autism or ADHDMatthew M Engelhard, Samuel I Berchuck, Jyotsna Garg, et al.
The Lancet. Oncology|August 3, 2011
Association between KRAS rs61764370 and triple-negative breast cancer--a false positive?Paul Pharoah, Antonis Antoniou, Andrew Berchuck, et al.
American Journal of Obstetrics and Gynecology|November 1, 1996
p53 overexpression in advanced-stage endometrial adenocarcinomaM F Kohler, P Carney, R Dodge, et al.
American Journal of Obstetrics and Gynecology|March 1, 1995
Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancerJ M Schildkraut, N K Collins, G A Dent, et al.
Ophthalmology. Glaucoma|March 4, 2026
The validity of the Distress Thermometer in patients with primary open-angle glaucomaNatalie Chou, Eun Young Choi, Hannah Fisher, et al.
Cancer|January 22, 2011
Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reductionLaura J Havrilesky, Gillian D Sanders, Shalini Kulasingam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristicsJ I Risinger, K Hayes, G L Maxwell, et al.
Cancer Research|April 15, 1993
Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expressionS Wu, C M Boyer, R S Whitaker, et al.
Gynecologic Oncology|February 13, 2001
K-ras mutations in Müllerian inclusion cysts associated with serous borderline tumors of the ovaryA A Alvarez, W F Moore, S J Robboy, et al.
Cancer|February 15, 1993
Cell growth regulation in epithelial ovarian cancerR C Bast, C M Boyer, I Jacobs, et al.
Pageof 69

Showing results (201-210 of 681) with videos related to

Sort By:
Pageof 69
Scientific Reports|October 20, 2020
Health system utilization before age 1 among children later diagnosed with autism or ADHDMatthew M Engelhard, Samuel I Berchuck, Jyotsna Garg, et al.
The Lancet. Oncology|August 3, 2011
Association between KRAS rs61764370 and triple-negative breast cancer--a false positive?Paul Pharoah, Antonis Antoniou, Andrew Berchuck, et al.
American Journal of Obstetrics and Gynecology|November 1, 1996
p53 overexpression in advanced-stage endometrial adenocarcinomaM F Kohler, P Carney, R Dodge, et al.
American Journal of Obstetrics and Gynecology|March 1, 1995
Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancerJ M Schildkraut, N K Collins, G A Dent, et al.
Ophthalmology. Glaucoma|March 4, 2026
The validity of the Distress Thermometer in patients with primary open-angle glaucomaNatalie Chou, Eun Young Choi, Hannah Fisher, et al.
Cancer|January 22, 2011
Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reductionLaura J Havrilesky, Gillian D Sanders, Shalini Kulasingam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristicsJ I Risinger, K Hayes, G L Maxwell, et al.
Cancer Research|April 15, 1993
Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expressionS Wu, C M Boyer, R S Whitaker, et al.
Gynecologic Oncology|February 13, 2001
K-ras mutations in Müllerian inclusion cysts associated with serous borderline tumors of the ovaryA A Alvarez, W F Moore, S J Robboy, et al.
Cancer|February 15, 1993
Cell growth regulation in epithelial ovarian cancerR C Bast, C M Boyer, I Jacobs, et al.
Pageof 69